{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T20:50:53Z","timestamp":1780692653405,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>African swine fever virus (ASFV) causes a highly contagious hemorrhagic disease that affects domestic pig and Eurasian wild boar populations. To date, no safe and efficacious treatment or vaccine against ASF is available. Nevertheless, there are several reports of protection elicited by experimental vaccines based on live attenuated ASFV and some levels of protection and reduced viremia in other approaches such as DNA, adenovirus, baculovirus, and vaccinia-based vaccines. Current ASF subunit vaccine research focuses mainly on delivering protective antigens and antigen discovery within the ASFV genome. However, due to the complex nature of ASFV, expression vectors need to be optimized to improve their immunogenicity. Therefore, in the present study, we constructed several recombinant MVA vectors to evaluate the efficiency of different promoters and secretory signal sequences in the expression and immunogenicity of the p30 protein from ASFV. Overall, the natural poxvirus PrMVA13.5L promoter induced high levels of both p30 mRNA and specific anti-p30 antibodies in mice. In contrast, the synthetic PrS5E promoter and the S E\/L promoter linked to a secretory signal showed lower mRNA levels and antibodies. These findings indicate that promoter selection may be as crucial as the antigen used to develop ASFV subunit vaccines using MVA as the delivery vector.<\/jats:p>","DOI":"10.1038\/s41598-021-02949-x","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T06:06:05Z","timestamp":1638770765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Optimization in the expression of ASFV proteins for the development of subunit vaccines using poxviruses as delivery vectors"],"prefix":"10.1038","volume":"11","author":[{"given":"Jaime","family":"Lopera-Madrid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lex G.","family":"Medina-Mag\u00fces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas P.","family":"Gladue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel V.","family":"Borca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"2949_CR1","first-page":"668","volume":"85","author":"J Parker","year":"1969","unstructured":"Parker, J., Plowright, W. & Pierce, M. A. The epizootiology of African swine fever in Africa. Vet. Rec. 85, 668\u2013674 (1969).","journal-title":"Vet. Rec."},{"key":"2949_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1135(98)00187-4","volume":"62","author":"E Anderson","year":"1998","unstructured":"Anderson, E., Hutchings, G., Mukarati, N. & Wilkinson, P. African swine fever virus infection of the bushpig (Potamochoerus porcus) and its significance in the epidemiology of the disease. Vet. Microbiol. 62, 1\u201315 (1998).","journal-title":"Vet. Microbiol."},{"key":"2949_CR3","first-page":"43","volume-title":"Current Topics in Microbiology and Immunology","author":"ER Tulman","year":"2009","unstructured":"Tulman, E. R., Delhon, G. A., Ku, B. K. & Rock, D. L. African swine fever virus. In Current Topics in Microbiology and Immunology 43\u201387 (Springer, 2009)."},{"key":"2949_CR4","first-page":"711","volume":"45","author":"FM Hamdy","year":"1984","unstructured":"Hamdy, F. M. & Dardiri, A. H. Clinical and immunologic responses of pigs to African swine fever virus isolated from the Western Hemisphere. Am. J. Vet. Res. 45, 711\u2013714 (1984).","journal-title":"Am. J. Vet. Res."},{"key":"2949_CR5","first-page":"1867","volume":"41","author":"CA Mebus","year":"1980","unstructured":"Mebus, C. A. & Dardiri, A. H. Western hemisphere isolates of African swine fever virus: Asymptomatic carriers and resistance to challenge inoculation. Am. J. Vet. Res. 41, 1867\u20131869 (1980).","journal-title":"Am. J. Vet. Res."},{"key":"2949_CR6","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1128\/JVI.74.3.1275-1285.2000","volume":"74","author":"T Lewis","year":"2000","unstructured":"Lewis, T. et al. An African swine fever virus ERV1-ALR Homologue, 9GL, affects virion maturation and viral growth in macrophages and viral virulence in swine. J. Virol. 74, 1275\u20131285 (2000).","journal-title":"J. Virol."},{"key":"2949_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.antiviral.2019.02.018","volume":"165","author":"LK Dixon","year":"2019","unstructured":"Dixon, L. K., Sun, H. & Roberts, H. African swine fever. Antiviral Res. 165, 34\u201341 (2019).","journal-title":"Antiviral Res."},{"key":"2949_CR8","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1128\/jvi.70.8.5689-5694.1996","volume":"70","author":"P G\u00f3mez-Puertas","year":"1996","unstructured":"G\u00f3mez-Puertas, P. et al. Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization. J. Virol. 70, 5689\u20135694 (1996).","journal-title":"J. Virol."},{"key":"2949_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/viro.1998.9068","volume":"243","author":"P G\u00f3mez-Puertas","year":"1998","unstructured":"G\u00f3mez-Puertas, P. et al. The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology 243, 461\u2013471 (1998).","journal-title":"Virology"},{"key":"2949_CR10","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s007050170056","volume":"146","author":"MG Barderas","year":"2001","unstructured":"Barderas, M. G. et al. Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins. Arch. Virol. 146, 1681\u20131691 (2001).","journal-title":"Arch. Virol."},{"key":"2949_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40813-019-0140-y","volume":"6","author":"L Bosch-Cam\u00f3s","year":"2020","unstructured":"Bosch-Cam\u00f3s, L., L\u00f3pez, E. & Rodriguez, F. African swine fever vaccines: A promising work still in progress. Porc. Heal. Manag. 6, 1\u201314 (2020).","journal-title":"Porc. Heal. Manag."},{"key":"2949_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2144\/04371RR02","volume":"37","author":"DB Boyle","year":"2004","unstructured":"Boyle, D. B., Anderson, M. A., Amos, R., Voysey, R. & Coupar, B. E. H. Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules. Biotechniques 37, 104\u2013111 (2004).","journal-title":"Biotechniques"},{"key":"2949_CR13","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1016\/j.vaccine.2008.09.044","volume":"26","author":"A Brun","year":"2008","unstructured":"Brun, A. et al. Antigen delivery systems for veterinary vaccine development. Vaccine 26, 6508\u20136528 (2008).","journal-title":"Vaccine"},{"key":"2949_CR14","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/v7041726","volume":"7","author":"L S\u00e1nchez-Sampedro","year":"2015","unstructured":"S\u00e1nchez-Sampedro, L. et al. The evolution of poxvirus vaccines. Viruses 7, 1726\u20131803 (2015).","journal-title":"Viruses"},{"key":"2949_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.vetimm.2017.01.004","volume":"185","author":"J Lopera-Madrid","year":"2017","unstructured":"Lopera-Madrid, J. et al. Safety and immunogenicity of mammalian cell derived and Modified Vaccinia Ankara vectored African swine fever subunit antigens in swine. Vet. Immunol. Immunopathol. 185, 20\u201333 (2017).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"2949_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/vaccines8020234","volume":"8","author":"LC Goatley","year":"2020","unstructured":"Goatley, L. C. et al. A pool of eight virally vectored African swine fever antigens protect pigs against fatal disease. Vaccines 8, 234 (2020).","journal-title":"Vaccines"},{"key":"2949_CR17","doi-asserted-by":"publisher","first-page":"e73511","DOI":"10.1371\/journal.pone.0073511","volume":"8","author":"ST Wennier","year":"2013","unstructured":"Wennier, S. T. et al. A novel naturally occurring tandem promoter in modified vaccinia virus Ankara drives very early gene expression and potent immune responses. PLoS ONE 8, e73511 (2013).","journal-title":"PLoS ONE"},{"key":"2949_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.2144\/97236st07","volume":"23","author":"S Chakrabarti","year":"1997","unstructured":"Chakrabarti, S., Sisler, J. R. & Moss, B. Compact, synthetic, vaccinia virus early\/late promoter for protein expression. Biotechniques 23, 1094\u20131097 (1997).","journal-title":"Biotechniques"},{"key":"2949_CR19","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.1128\/JVI.00604-10","volume":"84","author":"K Baur","year":"2010","unstructured":"Baur, K. et al. Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses. J. Virol. 84, 8743\u20138752 (2010).","journal-title":"J. Virol."},{"key":"2949_CR20","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.vaccine.2013.01.038","volume":"31","author":"JN Brewoo","year":"2013","unstructured":"Brewoo, J. N. et al. Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice. Vaccine 31, 1848\u20131855 (2013).","journal-title":"Vaccine"},{"key":"2949_CR21","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1086\/593020","volume":"198","author":"EH Wilson","year":"2008","unstructured":"Wilson, E. H. & Hunter, C. A. Immunodominance and recognition of intracellular pathogens. J. Infect. Dis. 198, 1579\u20131581 (2008).","journal-title":"J. Infect. Dis."},{"key":"2949_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/21645515.2018.1513439","volume":"15","author":"NK Alharbi","year":"2019","unstructured":"Alharbi, N. K. Poxviral promoters for improving the immunogenicity of MVA delivered vaccines. Hum. Vacc. Immunother. 15, 203\u2013209 (2019).","journal-title":"Hum. Vacc. Immunother."},{"key":"2949_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2011.12.014","volume":"148","author":"G Li","year":"2012","unstructured":"Li, G. et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148, 84\u201398 (2012).","journal-title":"Cell"},{"key":"2949_CR24","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1084\/jem.20070489","volume":"204","author":"W Kastenmuller","year":"2007","unstructured":"Kastenmuller, W. et al. Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J. Exp. Med. 204, 2187\u20132198 (2007).","journal-title":"J. Exp. Med."},{"key":"2949_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1128\/JVI.02219-17","volume":"92","author":"JK Jancovich","year":"2018","unstructured":"Jancovich, J. K. et al. Immunization of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank african swine fever virus immunogenic and protective proteins. J. Virol. 92, 17 (2018).","journal-title":"J. Virol."},{"key":"2949_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01318","volume":"10","author":"CL Netherton","year":"2019","unstructured":"Netherton, C. L. et al. Identification and immunogenicity of African swine fever virus antigens. Front. Immunol. 10, 1\u201321 (2019).","journal-title":"Front. Immunol."},{"key":"2949_CR27","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1016\/j.vaccine.2010.06.054","volume":"28","author":"JN Brewoo","year":"2010","unstructured":"Brewoo, J. N., Powell, T. D., Stinchcomb, D. T. & Osorio, J. E. Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice. Vaccine 28, 5891\u20135899 (2010).","journal-title":"Vaccine"},{"key":"2949_CR28","doi-asserted-by":"publisher","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","volume":"89","author":"G Sutter","year":"1992","unstructured":"Sutter, G. & Moss, B. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. 89, 10847\u201310851 (1992).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2949_CR29","first-page":"1","volume-title":"Current Protocols in Protein Science","author":"PL Earl","year":"1998","unstructured":"Earl, P. L., Cooper, N., Wyatt, L. S., Moss, B. & Carroll, M. W. Preparation of cell cultures and vaccinia virus stocks. In Current Protocols in Protein Science 1\u201312 (John Wiley & Sons Inc, 1998)."},{"key":"2949_CR30","first-page":"13","volume":"5","author":"PL Earl","year":"2001","unstructured":"Earl, P. L., Moss, B., Wyatt, L. S. & Carroll, M. W. Generation of recombinant vaccinia viruses. Curr. Protoc. Protein Sci. 5, 13 (2001).","journal-title":"Curr. Protoc. Protein Sci."},{"key":"2949_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1385\/1-59259-789-0:077","volume-title":"Vaccinia Virus and Poxvirology","author":"C Staib","year":"2004","unstructured":"Staib, C., Drexler, I. & Sutter, G. Construction and isolation of recombinant MVA. In Vaccinia Virus and Poxvirology 77\u201399 (Humana Press, 2004)."},{"key":"2949_CR32","unstructured":"NIH. ImageJ. Available at: https:\/\/imagej.nih.gov\/ij\/."},{"key":"2949_CR33","unstructured":"Thermofisher scientific. Normalization in western blotting to obtain relative quantitation. Thermofisher scientific (2018). Available at: https:\/\/assets.thermofisher.com\/TFS-Assets\/BID\/Technical-Notes\/ibright-normalization-western-blotting-relative-quantitation-technical-note.pdf. (Accessed: 3rd October 2021)"},{"key":"2949_CR34","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/tbed.13826","volume":"68","author":"DK Meza","year":"2021","unstructured":"Meza, D. K. et al. Predicting the presence and titre of rabies virus-neutralizing antibodies from low-volume serum samples in low-containment facilities. Transbound. Emerg. Dis. 68, 1564\u20131576 (2021).","journal-title":"Transbound. Emerg. Dis."},{"key":"2949_CR35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02949-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:54:07Z","timestamp":1670072047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02949-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2949"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-02949-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-865456\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,6]]},"assertion":[{"value":"1 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23476"}}